Publications

Fairlane, a Double-Blind Placebo-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Early Triple-Negative Breast Cancer

AuthID
P-00R-3VP

Author(s)

Oliveira, M

Saura, C

Nuciforo, P

Calvo, I

Andersen, J

Passos Coelho, JL

Gil Gil, MG

Bermejo, B

Patt, DA

Ciruelos, E

de la Pena, L

Xu, N

Wongchenko, M

Shi, Z

Singel, SM

Isakoff, SJ

Document Type

Article

Year published

2019

Published

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 30, Issue: 8, Pages: 1289-1297 (9)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/annonc/mdz177

Pubmed: 31147675

Scopus: 2-s2.0-85072722257

Wos: WOS:000493072600013

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Fairlane, a Double-Blind Placebo-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Early Triple-Negative Breast Cancer

Useful Links

Get Help

Federated Authentication (Click on the image)

Fairlane, a Double-Blind Placebo-Controlled Randomized Phase Ii Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Early Triple-Negative Breast Cancer

Useful Links

Get Help